Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate Cancer.

Authors	Ivan de Kouchkovsky, Hsin-Yu Chen, Michael A Ohliger, Zhen J Wang, Robert A Bok, Jeremy W Gordon, Peder E Z Larson, Mary Frost, Kimberly Okamoto, Matthew R Cooperberg, John Kurhanewicz, Daniel B Vigneron, Rahul Aggarwal
Journal	European urology (Eur Urol) Vol. 81 Issue 2 Pg. 219-221 (02 2022) ISSN: 1873-7560 [Electronic] Switzerland
PMID	34758912 (Publication Type: Letter, Research Support, N.I.H., Extramural)
Chemical References	Immune Checkpoint Inhibitors Pyruvic Acid
Topics	Humans Immune Checkpoint Inhibitors Magnetic Resonance Imaging (methods) Male Prostatic Neoplasms (diagnostic imaging, drug therapy, metabolism) Pyruvic Acid Radioimmunotherapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!